Evidence map›Paper›PMID 42853605›Full record

ArticleeLife2026

A membrane-disruptive action of VBIT-4 challenges its role as a widely used VDAC1 oligomerization inhibitor.

Varun Ravishankar, Luís Borges-Araújo, Megha Rajendran, Elodie Lafargue, Deborah Byrne, Nicolas Buzhinsky, Mya S Wolfe, Wendy Fitzgerald, Nina A Bautista, Bethel G Beyene and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in eLife, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Varun Ravishankar *Laboratoire d'Ingénierie des Systèmes Macromoléculaires, CNRS, UMR 7255 - Aix-Marseille Université, Marseille, France.ORCID https://orcid.org/0009-0007-6890-6924
Luís Borges-Araújo *Laboratoire de Biologie et Modélisation de la Cellule, CNRS, UMR 5239, Inserm, U1293, Université Claude Bernard Lyon 1, Ecole Normale Supérieure de Lyon, Lyon, France.ORCID https://orcid.org/0000-0003-3004-7750
Megha Rajendran *Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, United States.ORCID https://orcid.org/0000-0001-8078-4738
Elodie LafargueU1325 Aix-Marseille Université, INSERM, DyNaMo, Turing Centre for Living System, Marseille, France.ORCID https://orcid.org/0009-0003-1737-9723
Deborah ByrneBiomass and Protein Engineering Aix-Marseille Université, CNRS, IMM UAR2044, Marseille, France.
Nicolas BuzhinskyU1325 Aix-Marseille Université, INSERM, DyNaMo, Turing Centre for Living System, Marseille, France.
Mya S WolfeEunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, United States.
Wendy FitzgeraldEunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, United States.
Nina A BautistaEunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, United States.
Bethel G BeyeneEunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, United States.
Motahareh G LarimiEunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, United States.
Jean-Pierre DuneauLaboratoire d'Ingénierie des Systèmes Macromoléculaires, CNRS, UMR 7255 - Aix-Marseille Université, Marseille, France.
James SturgisLaboratoire d'Ingénierie des Systèmes Macromoléculaires, CNRS, UMR 7255 - Aix-Marseille Université, Marseille, France.
Sergey M BezrukovEunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, United States.ORCID https://orcid.org/0000-0002-8209-8050
Ignacio CasusoU1325 Aix-Marseille Université, INSERM, DyNaMo, Turing Centre for Living System, Marseille, France.ORCID https://orcid.org/0000-0001-7192-0136
Tatiana K RostovtsevaEunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, United States.ORCID https://orcid.org/0000-0001-7299-7362
Lucie BergdollLaboratoire d'Ingénierie des Systèmes Macromoléculaires, CNRS, UMR 7255 - Aix-Marseille Université, Marseille, France.ORCID https://orcid.org/0000-0001-6068-238X

Funding

Agence Nationale de la Recherche ApoMitoAix-Marseille Université AMX-21-PEP-022NIH HHS ZIA HD000072-18
6 · The paper itself

Abstract

Voltage-dependent anion channel (VDAC) is the most abundant protein of the mitochondrial outer membrane and a key regulator of metabolite exchange and mitochondrial physiology. Its oligomerization has been proposed to control processes such as mitochondrial DNA release and membrane remodeling, yet the underlying mechanisms remain poorly defined. VBIT-4 has been widely used as a putative inhibitor of VDAC1 oligomerization, despite limited mechanistic validation. Here, using high-speed atomic force microscopy (AFM), we visualized VDAC1 assemblies in lipid membranes and examined the effect of VBIT-4. Unexpectedly, VBIT-4 induced membrane defects and permeabilization at micromolar concentrations, independently of VDAC1. Quantitative AFM analysis further shows that VBIT-4 does not alter VDAC1 cluster organization. Complementary electrophysiology, microscale thermophoresis, and coarse-grained molecular dynamics demonstrate that VBIT-4 partitions into lipid bilayers, increases membrane permeability, and destabilizes membrane structure, without detectable effects on VDAC1 channel properties or assemblies. Consistent with this mechanism, VBIT-4 induces VDAC1-independent cytotoxicity in HeLa cells at concentrations above 10 µM. Together, these results demonstrate that VBIT-4 does not act as a specific inhibitor of VDAC1 oligomerization but instead functions as a membrane-active compound. This work provides a revised framework for interpreting studies using VBIT-4 and highlights the importance of systematically assessing drug-membrane interactions when targeting membrane proteins.

Indexed as

Mitochondrial MembranesProtein MultimerizationVoltage-Dependent Anion Channel 1HeLa CellsHumansMicroscopy, Atomic ForceVDAC1 protein, humanVoltage-Dependent Anion Channel 1biochemistrychemical biologycytotoxicitymembrane destabilizationmitochondrial outer membraneoligomerizationVBIT-4voltage-dependent anion channel

Identifiers

PMID42853605

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.